Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2012

Open Access 01-12-2012 | Research

Transcriptome analysis of the ependymal barrier during murine neurocysticercosis

Authors: Pramod Kumar Mishra, Judy M Teale

Published in: Journal of Neuroinflammation | Issue 1/2012

Login to get access

Abstract

Background

Central nervous system (CNS) barriers play a pivotal role in the protection and homeostasis of the CNS by enabling the exchange of metabolites while restricting the entry of xenobiotics, blood cells and blood-borne macromolecules. While the blood–brain barrier and blood-cerebrospinal fluid barrier (CSF) control the interface between the blood and CNS, the ependyma acts as a barrier between the CSF and parenchyma, and regulates hydrocephalic pressure and metabolic toxicity. Neurocysticercosis (NCC) is an infection of the CNS caused by the metacestode (larva) of Taenia solium and a major cause of acquired epilepsy worldwide. The common clinical manifestations of NCC are seizures, hydrocephalus and symptoms due to increased intracranial pressure. The majority of the associated pathogenesis is attributed to the immune response against the parasite. The properties of the CNS barriers, including the ependyma, are affected during infection, resulting in disrupted homeostasis and infiltration of leukocytes, which correlates with the pathology and disease symptoms of NCC patients.

Results

In order to characterize the role of the ependymal barrier in the immunopathogenesis of NCC, we isolated ependymal cells using laser capture microdissection from mice infected or mock-infected with the closely related parasite Mesocestoides corti, and analyzed the genes that were differentially expressed using microarray analysis. The expression of 382 genes was altered. Immune response-related genes were verified by real-time RT-PCR. Ingenuity Pathway Analysis (IPA) software was used to analyze the biological significance of the differentially expressed genes, and revealed that genes known to participate in innate immune responses, antigen presentation and leukocyte infiltration were affected along with the genes involved in carbohydrate, lipid and small molecule biochemistry. Further, MHC class II molecules and chemokines, including CCL12, were found to be upregulated at the protein level using immunofluorescence microcopy. This is important, because these molecules are members of the most significant pathways by IPA analyses.

Conclusion

Thus, our study indicates that ependymal cells actively express immune mediators and likely contribute to the observed immunopathogenesis during infection. Of particular interest is the major upregulation of antigen presentation pathway-related genes and chemokines/cytokines. This could explain how the ependyma is a prominent source of leukocyte infiltration into ventricles through the disrupted ependymal lining by way of pial vessels present in the internal leptomeninges in murine NCC.
Appendix
Available only for authorised users
Literature
1.
2.
Alvarez JI, et al.: Mesocestoides corti intracranial infection as a murine model for neurocysticercosis. Parasitology 2010,137(3):359–372.CrossRefPubMed
3.
Alvarez JI, Teale JM: Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis. J Neuroimmunol 2007,187(1–2):102–113.CrossRefPubMedPubMedCentral
4.
Alvarez JI, Teale JM: Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res 2007, 1169:98–111.CrossRefPubMedPubMedCentral
5.
Alvarez JI, Teale JM: Multiple expression of matrix metalloproteinases in murine neurocysticercosis: implications for leukocyte migration through multiple central nervous system barriers. Brain Res 2008, 1214:145–158.CrossRefPubMedPubMedCentral
6.
Ransohoff RM, Kivisakk P, Kidd G: Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003,3(7):569–581.CrossRefPubMed
7.
Del Bigio MR: The ependyma: a protective barrier between brain and cerebrospinal fluid. Glia 1995,14(1):1–13.CrossRefPubMed
8.
Bruni JE: Ependymal development, proliferation, and functions: a review. Microsc Res Tech 1998,41(1):2–13.CrossRefPubMed
9.
Yamamoto T, et al.: Differential anatomical and cellular patterns of connexin43 expression during postnatal development of rat brain. Brain Res Dev Brain Res 1992,66(2):165–180.CrossRefPubMed
10.
Jarvis CR, Andrew RD: Correlated electrophysiology and morphology of the ependyma in rat hypothalamus. J Neurosci 1988,8(10):3691–3702.PubMed
11.
Lippoldt A, et al.: Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma. Brain Res 2000,854(1–2):197–206.CrossRefPubMed
12.
Abramovitz M, et al.: Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 1988,50(1):50–57.CrossRefPubMed
13.
Carder PJ, et al.: Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol 1990,16(4):293–303.CrossRefPubMed
14.
Saura J, Richards JG, Mahy N: Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging 1994,15(4):399–408.CrossRefPubMed
15.
Williams D, et al.: Histochemical characterization of monoamine oxidase in ependyma of rat hypothalamus. Histochem J 1979,11(1):83–95.CrossRefPubMed
16.
Jung JS, et al.: Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 1994,91(26):13052–13056.CrossRefPubMedPubMedCentral
17.
Mishra BB, Mishra PK, Teale JM: Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 2006,181(1–2):46–56.CrossRefPubMedPubMedCentral
18.
Cardona AE, et al.: Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J Immunol 1999,162(2):995–1002.PubMed
19.
Mishra BB, Gundra UM, Teale JM: STAT6/mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. J Neuroimmunol 2011,232(1–2):26–34.CrossRefPubMed
20.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 2001,25(4):402–408.CrossRefPubMed
21.
Alvarez JI, Teale JM: Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J Neuroimmunol 2006,173(1–2):45–55.CrossRefPubMed
22.
Toyama-Sorimachi N, et al.: Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem 1997,272(42):26714–26719.CrossRefPubMed
23.
Wang S, et al.: Loss of Myt1 function partially compromises endocrine islet cell differentiation and pancreatic physiological function in the mouse. Mech Dev 2007,124(11–12):898–910.CrossRefPubMedPubMedCentral
24.
Vanhorenbeeck V, et al.: Role of the Onecut transcription factors in pancreas morphogenesis and in pancreatic and enteric endocrine differentiation. Dev Biol 2007,305(2):685–694.CrossRefPubMed
25.
Margagliotti S, et al.: The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol 2007,311(2):579–589.CrossRefPubMed
26.
Zhou Y, et al.: The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis. Cell 2007,129(1):163–178.CrossRefPubMed
27.
28.
Hawkins BT, Egleton RD: Pathophysiology of the blood–brain barrier: animal models and methods. Curr Top Dev Biol 2008, 80:277–309.CrossRefPubMed
29.
Engelhardt B, Sorokin L: The blood–brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 2009,31(4):497–511.CrossRefPubMed
30.
31.
Letiembre M, et al.: Innate immune receptor expression in normal brain aging. Neuroscience 2007,146(1):248–254.CrossRefPubMed
32.
Xia Y, Yamagata K, Krukoff TL: Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.c.v. administration of LPS. Brain Res 2006,1095(1):85–95.CrossRefPubMed
33.
French RA, et al.: Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol 1999,93(1–2):194–202.CrossRefPubMed
34.
Sugama S, et al.: Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res 2002,958(1):1–9.CrossRefPubMed
35.
Garcia HH, Del Brutto OH: Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005,4(10):653–661.CrossRefPubMed
36.
Vargas JD, et al.: Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta 2003,1651(1–2):116–123.CrossRefPubMed
37.
Genzen JR, et al.: Activation of adenosine A2B receptors enhances ciliary beat frequency in mouse lateral ventricle ependymal cells. Cerebrospinal Fluid Res 2009, 6:15.CrossRefPubMedPubMedCentral
38.
Morishita Y, et al.: Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol 2005,25(17):7770–7779.CrossRefPubMedPubMedCentral
39.
Liu RZ, et al.: Fatty acid binding proteins in brain development and disease. Int J Dev Biol 2010,54(8–9):1229–1239.CrossRefPubMed
40.
Dreuw A, et al.: Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol 2005,124(1):28–37.CrossRefPubMed
41.
Obregon-Henao A, et al.: The role of N-linked carbohydrates in the antigenicity of Taenia solium metacestode glycoproteins of 12, 16 and 18 kD. Mol Biochem Parasitol 2001,114(2):209–215.CrossRefPubMed
42.
Restrepo BI, et al.: Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am J Trop Med Hyg 2001,65(4):366–370.PubMed
43.
Lopez-Marin LM, et al.: Structure and antigenicity of the major glycolipid from Taenia solium cysticerci. Mol Biochem Parasitol 2002,119(1):33–42.CrossRefPubMed
44.
Obregon-Henao A, et al.: In situ detection of antigenic glycoproteins in Taenia solium metacestodes. J Parasitol 2003,89(4):726–732.CrossRefPubMed
45.
Alvarez JI, Rivera J, Teale JM: Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl Trop Dis 2008,2(4):e218.CrossRefPubMedPubMedCentral
46.
Estes DM, Teale JM: Biochemical and functional analysis of extracellular stress proteins of Mesocestoides corti. J Immunol 1991,147(11):3926–3934.PubMed
47.
Fleury A, et al.: Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 2010,104(4):243–250.CrossRefPubMed
48.
Mabey DC, et al.: Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease. J Clin Pathol 1991,44(4):285–289.CrossRefPubMedPubMedCentral
49.
Alldinger S, et al.: Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol 1996,92(3):273–280.CrossRefPubMed
50.
Engelhardt B, Wolburg-Buchholz K, Wolburg H: Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 2001,52(1):112–129.CrossRefPubMed
51.
Flugel A, et al.: Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J Neuroimmunol 2007,191(1–2):86–97.CrossRefPubMed
52.
Uetani K, et al.: Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway. Eur J Immunol 2008,38(6):1559–1573.CrossRefPubMed
53.
Reith W, LeibundGut-Landmann S, Waldburger JM: Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005,5(10):793–806.CrossRefPubMed
54.
55.
Steiniger B, van der Meide PH: Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J Neuroimmunol 1988,19(1–2):111–118.CrossRefPubMed
56.
Nonaka M, et al.: GM-CSF, IL-8, IL-1R, TNF-alpha R, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med 1996,153(5):1675–1681.CrossRefPubMed
57.
Aubert V, et al.: Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1. Infect Immun 2000,68(1):120–124.CrossRefPubMedPubMedCentral
58.
Kalb TH, et al.: Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991,4(4):320–329.CrossRefPubMed
59.
Rossi GA, et al.: Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol 1990,3(5):431–439.CrossRefPubMed
60.
Siebert H, et al.: The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 2000,110(1–2):177–185.CrossRefPubMed
61.
62.
Rebenko-Moll NM, et al.: Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol 2006,18(6):683–689.CrossRefPubMed
63.
Viola A, Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008, 48:171–197.CrossRefPubMed
64.
Stiles LN, et al.: Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol 2006,36(3):613–622.CrossRefPubMed
65.
Cuetter AC, et al.: Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 1997,24(2):157–164.CrossRefPubMed
66.
Cuetter AC, Andrews RJ: Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. Neurosurg Focus 2002,12(6):e5.CrossRefPubMed
67.
Garcia HH, et al.: New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 2005,72(1):3–9.PubMed
68.
69.
Fleury A, et al.: Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2011,9(1):123–133.CrossRefPubMed
70.
Couldwell WT: Intraventricular neurocysticercosis. J Neurosurg 2003,98(3):648. author reply 648–9.PubMed
Metadata
Title
Transcriptome analysis of the ependymal barrier during murine neurocysticercosis
Authors
Pramod Kumar Mishra
Judy M Teale
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2012
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-9-141

Other articles of this Issue 1/2012

Journal of Neuroinflammation 1/2012 Go to the issue

Research

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study

Research

Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro

Research

P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand

Research

Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice

Research

Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling

Research

Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system